0001104659-23-006235.txt : 20230124 0001104659-23-006235.hdr.sgml : 20230124 20230124170051 ACCESSION NUMBER: 0001104659-23-006235 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230120 FILED AS OF DATE: 20230124 DATE AS OF CHANGE: 20230124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Palczuk Linda CENTRAL INDEX KEY: 0001717580 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37977 FILM NUMBER: 23548838 MAIL ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVADEL PHARMACEUTICALS PLC CENTRAL INDEX KEY: 0001012477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK STREET 2: BALLYCOOLIN CITY: DUBLIN STATE: L2 ZIP: 15 BUSINESS PHONE: 636-449-1830 MAIL ADDRESS: STREET 1: 16640 CHESTERFIELD GROVE ROAD STREET 2: SUITE 200 CITY: CHESTERFIELD STATE: MO ZIP: 63005 FORMER COMPANY: FORMER CONFORMED NAME: FLAMEL TECHNOLOGIES SA DATE OF NAME CHANGE: 19960422 4 1 tm234325-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2023-01-20 0 0001012477 AVADEL PHARMACEUTICALS PLC AVDL 0001717580 Palczuk Linda C/O AVADEL PHARMACEUTICALS PLC 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 IRELAND 1 0 0 0 Stock Option (Right to Buy) 2.03 2023-01-20 5 G 0 E 60000 0 D 2029-08-07 ADSs 60000 0 D Stock Option (Right to Buy) 2.03 2029-08-07 ADSs 60000 60000 I By Trust Stock Option (Right to Buy) 8.48 2023-01-20 5 G 0 E 42000 0 D 2030-08-07 ADSs 42000 0 D Stock Option (Right to Buy) 8.48 2030-08-07 ADSs 42000 42000 I By Trust Stock Option (Right to Buy) 8.07 2023-01-20 5 G 0 E 42000 0 D 2031-08-03 ADSs 42000 0 D Stock Option (Right to Buy) 8.07 2031-08-03 ADSs 42000 42000 I By Trust Stock Option (Right to Buy) 4.79 2023-01-20 5 G 0 E 42000 0 D 2032-08-03 ADSs 42000 0 D Stock Option (Right to Buy) 4.79 2032-08-03 ADSs 42000 42000 I By Trust These options are fully vested and exercisable as of the date hereof. The Issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts. On January 20, 2023, the Reporting Person transferred an aggregate of 186,000 options to a revocable trust of which the Reporting Person is trustee. These options become exercisable as to 14,000 ADSs on each of the first three anniversaries after the 08/07/2020 grant date, subject to the Reporting Person's continued service at each such vesting date. These options shall vest in full on the earlier to occur of (a) August 3, 2023 or (b) the date of the next annual general meeting of shareholders following the date of grant, subject to the Reporting Person's continued service on the Board of Directors at such time. /s/ Jerad G. Seurer, as attorney-in-fact 2023-01-24